SERM Medical Director
Provides medical and scientific leadership in the safety evaluation and risk management of GSK’s oncology assets in clinical development. Interprets safety data, identifies and escalates safety signals, and delivers evidence-based recommendations to inform benefit–risk decisions. Engages with global governance, regulatory authorities, and cross-functional teams to shape the safety profile of innovative oncology medicines.